Intellectual Property India Publishes Patent Application for 'BRM Targeting Compounds And Associated Methods Of Use' Filed by Prelude Therapeutics Incorporated

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053525 A) filed by Prelude Therapeutics Incorporated, Wilmington, U.S.A., on June 2, for 'brm targeting compounds and associated methods of use.'

Inventor(s) include Basch, Corey Howard; Mei, Song; Lu, Liang; Shvartsbart, Artem; Combs, Andrew Paul; and Rezazadeh, Sina.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides bifunctional compounds comprising a target protein binding moiety and a E3 ubiquitin ligase binding moiety, and associated methods of use."

The patent application was internationally filed on Nov. 14, 2023, under International application No.PCT/US2023/079618.

Disclaimer: Curated by HT Syndication.